Agenda

2022 CONFERENCE AGENDA

logo

General Session

Coastal ABCD 1-5

Clinical/Pharmacy Track

Coastal 6-10

Business Track

Coastal ABCD 1-5

WEDNESDAY, MARCH 16, 2022
5:30 - 7:00 PM EDT

President’s Reception in St. Augustine Atrium

THURSDAY, MARCH 17, 2022
6:30 - 7:30 AM EDT

Registration & Buffet Breakfast in the Exhibit Hall

7:30 - 7:55 AM EDT

Conference Opening Day One: Welcome From the Co-Chairs

  • Stephen “Fred” Divers, MD, Medical Oncologist, Genesis Cancer & Blood Institute & American Oncology Network
  • Debra Patt, MD, PhD, MBA, Vice President, Texas Oncology & The US Oncology Network
  • Jeffrey M. Patton, MD, Chief Executive Officer, OneOncology, Chairman of the Board, Tennessee Oncology
  • Alti Rahman, MHA, MBA, CSSBB, Practice Administrator, Oncology Consultants
  • Barry Russo, MBA, Chief Executive Officer, The Center for Cancer & Blood Disorders & OneOncology
  • Jeffrey Vacirca, MD, FACP, Chief Executive Officer, New York Cancer & Blood Specialists & OneOncology
8:00 - 8:45 AM EDT

KEYNOTE: Baseball, Cancer, Recovery: The Trey Mancini (Baltimore Orioles) Story

8:50 - 9:35 AM EDT

Building/Designing the Community Oncology Practice of the Future

  • Glenn Balasky, Executive Director, Rocky Mountain Cancer Centers
  • Barry Russo, MBA, Chief Executive Officer, The Center for Cancer & Blood Disorders & OneOncology,
    • Moderator
  • Emily Touloukian, DO, President, Coastal Cancer Center
  • Jeffrey Vacirca, MD, FACP, Chief Executive Officer, New York Cancer & Blood Specialists & OneOncology
9:40 - 10:25 AM EDT

Has Price Competition Come to Biologics & Competitive Cancer Drugs?

  • Aharon “Ronny” Gal, PhD, Moto Bioadvisors
10:25 - 11:00 AM EDT

Networking in the Exhibit Hall

11:00 – 11:45 AM EDT

Treatment Conundrums in Myeloma

  • Sergio Giralt, MD, FACP, FASTCT, Deputy Head, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center

Battle Royale: Payer Utilization Management vs. Physician-Directed Medicine

  • Leslie Busby, MD, Chairman of the US Oncology Network Pharmacy & Therapeutics Committee, Rocky Mountain Cancer Centers
  • Barbara McAneny, MD, Chief Executive Officer, New Mexico Cancer Center
  • Debra Patt, MD, PhD, MBA, Vice President, Texas Oncology & The US Oncology Network, Moderator
11:50 AM – 12:35 PM EDT

The Colorectal Cancer Epidemic: Root Causes & Remedies

  • Richard Goldberg, MD, Emeritus Professor, Cancer Institute Director, West Virginia University

Community Oncology Practices & Employers Partnering to Deliver High-Quality, Affordable Cancer Care

  • Robert Baird, Jr., RN, MSA, President, National Cancer Treatment Alliance, Moderator
  • Steven D’Amato, BScPharm, Chair, Data Use Committee, Cancer Pharmacy Network
  • Alti Rahman, MHA, MBA, CSSBB, Practice Administrator, Oncology Consultants
  • Chris Skisak, PhD, Executive Director, Houston Business Coalition on Health
12:35 – 1:35 PM EDT

Lunch & Networking in the Exhibit Hall

1:35 – 2:20 PM EDT

Latest Approaches in the Treatment of Adjuvant Breast Cancer

  • Ruth O’Regan, MD, Chair, Department of Medicine, Charles A. Dewey Endowed Professor, University of Rochester

Employer/Payer Alert: Why the Site of Cancer Care Delivery Matters

  • Michael Diaz, MD, President & Managing Physician, Florida Cancer Specialists & Research Institute, Immediate Past President, Community Oncology Alliance
2:25 – 3:20 PM EDT

Pharmacy Benefit Managers (PBMs): Legal & Legislative Actions to Curb Abuses

  • Jonathan E. Levitt, Esq., Founding Partner, Frier Levitt
  • Jeff Mortier, Co-Founder & Partner, Farragut Partners
  • Ted Okon, MBA, Executive Director, Community Oncology Alliance, Moderator
3:20 – 3:50 PM EDT

Networking in the Exhibit Hall

3:50 – 4:35 PM EDT

Exciting New Drugs in Non-Small Cell Lung Cancer

  • Melissa Johnson, MD, Program Director, Lung Cancer Research, Sarah Cannon Research Institute

Dealing with Physician, Staff & Administrator Burnout: Lessons From COVID-19

  • Bo Gamble, Director of Quality & Value Initiatives, Community Oncology Alliance, Moderator
  • Desiree Johnson, MHA, SHRM-SCP, Director of Human Resources, Oncology Consultants
  • Steve Kennedy, Senior Vice President, Human Resources, Tennessee Oncology
  • Elizabeth Spurlock, MA, PHR, Director, Human Resource Business Partners, Texas Oncology
4:40 – 5:25 PM EDT

Tackling Cancer Health Equity: Community Oncology Practices in Action

  • Nicolas Ferreyros, Managing Director, Policy, Advocacy & Communications, Community Oncology Alliance, Moderator
  • Patricia J. Goldsmith, Chief Executive Officer, CancerCare
  • Kashyap Patel, MD, Chief Executive Officer, Carolina Blood & CancerCare Associates, President, Community Oncology Alliance
  • Susan Sabo-Wagner, RN, BSN, OCN, Clinical Director, Oncology Consultants
5:30 – 6:30 PM EDT

Networking & Refreshments in the Exhibit Hall

FRIDAY, MARCH 18, 2022
6:30 - 7:30 AM EDT

Registration & Buffet Breakfast in the Exhibit Hall

7:30 – 8:00 AM EDT

Conference Opening Day Two: Update From the Co-Chairs

  • Stephen “Fred” Divers, MD, Medical Oncologist, Genesis Cancer & Blood Institute & American Oncology Network
  • Debra Patt, MD, PhD, MBA, Vice President, Texas Oncology & The US Oncology Network
  • Jeffrey M. Patton, MD, Chief Executive Officer, OneOncology, Chairman of the Board, Tennessee Oncology
  • Alti Rahman, MHA, MBA, CSSBB, Practice Administrator, Oncology Consultants
  • Barry Russo, MBA, Chief Executive Officer, The Center for Cancer & Blood Disorders & OneOncology
  • Jeffrey Vacirca, MD, FACP, Chief Executive Officer, New York Cancer & Blood Specialists & OneOncology
8:05 – 8:50 AM EDT

Moving the Needle in Comprehensive Genomic Profiling

  • Richard M. “Mike” Barlow, Principal, Barlow Advisers, LLC
  • Debra Patt, MD, PhD, MBA, Vice President, Texas Oncology & The US Oncology Network, Moderator
  • William K. Oh, MD, Chief Medical Science Officer, Sema4
  • Prasanth Reddy, MD, MPH, FACP, Senior Vice President, Global Enterprise Oncology Head, Covance/Labcorp Drug Development

Understanding & Implementing New Codes in Cancer Care: What Are You Missing?

  • Roberta Buell, MBA, Principal, Provider Services & Reimbursement Information, onPoint Oncology Inc.
  • Bo Gamble, Director of Quality & Value Initiatives, Community Oncology AllianceModerator
  • Julia Harwood, Vice President, Clinical Operations, New York Cancer & Blood Specialists
  • Colt Hatcher, MHA, Director of Business Services, The Center for Cancer & Blood Disorders
8:55 – 9:55 AM EDT

Legislative Update From Capitol Hill: Cancer Politics & Policy in Washington, D.C.

  • Nathan Constable, Manager, Government Relations, Cardinal Health
  • Christian G. Downs, JD, MHA, Executive Director, Association of Community Cancer Centers
  • Ben Jones, Vice President, Government Relations & Public Policy, The US Oncology Network
  • Deborah Kamin, RN, PhD, Vice President, Policy & Advocacy, American Society of Clinical Oncology
  • Rita Norton, Senior Vice President, Government Affairs, AmerisourceBergen Corporation
  • Ted Okon, MBA, Executive Director, Community Oncology Alliance, Moderator
9:55 – 10:25 AM EDT

Networking in the Exhibit Hall

10:25 – 11:10 AM EDT

Evolution & Disruption In U.S. Drug Channels

  • Adam J. Fein, PhD, Chief Executive Officer, Drug Channels Institute
11:15 AM – 12:00 PM EDT

Cancer Drug Development: Where is the Science Taking Us?

  • Johanna Bendell, MD, Global Head Oncology, Pharma Research & Early Development, Roche
  • Jeff Infante, MD, Global Head of Oncology, Early Development & Translational Research, Oncology, Janssen
  • Jeffrey M. Patton, MD, Chief Executive Officer, OneOncology, Chairman of the Board, Tennessee Oncology, Moderator
12:00 – 12:55 PM EDT

Lunch & Networking in Exhibit Hall

12:55 – 1:45 PM EDT

The New World of Oral Cancer Drug Dispensing: Pharmacy Challenges & Solutions

  • Ray Bailey, RPh, Vice President of Pharmacy, Rx To Go/Florida Cancer Specialists & Research Institute
  • Jim Schwartz, RPh, Corporate Pharmacy Manager, Texas Oncology

State of the Art Health Economics & Outcomes: What Community Oncology Practices Are Tracking & Measuring

  • Alti Rahman, MHA, MBA, CSSBB, Practice Administrator, Oncology Consultants, Moderator
  • Stephen Schleicher, MD, MBA, Medical Director, Value Based Care, Tennessee Oncology & OneOncology, President, Tennessee Oncology Practice Society
  • Lalan Wilfong, MD, Vice President, Payer Relations & Practice Transformation, The US Oncology Network, McKesson
1:50 – 2:35 PM EDT

Going After Pharmacy Benefit Managers (PBMs) at the State Level

  • Michael Diaz, MD, President & Managing Physician, Florida Cancer Specialists & Research Institute, Immediate Past President, Community Oncology Alliance
  • David Eagle, MD, Chair of Legislative Affairs & Patient Advocacy, New York Cancer & Blood Specialists, Moderator
  • Greg Reybold, Esq., Director of Healthcare Policy & General Counsel, American Pharmacy Cooperative, Inc.
  • Angela Storseth-Cooper, Associate Director of Government Relations & Public Policy, The US Oncology Network
  • Monique Whitney, Executive Director, Pharmacists United for Truth & Transparency

Becoming a Certified Oncology Medical Home: Quality, Outcomes, Value

  • Ronda Bowman, MHA, RN, OCN, Director, Patient-Centered Cancer Care, American Society of Clinical Oncology
  • Natalie Dickson, MD, MMHC, FACP, President, Chief Strategy Officer, Tennessee Oncology
  • Bo Gamble, Director of Quality & Value Initiatives, Community Oncology Alliance, Moderator
  • Stephen Grubbs, MD, FASCO, Vice President, Care Delivery, American Society of Clinical Oncology
  • Matthew R. Skelton, MD, Medical Oncologist, Blue Ridge Cancer Care
2:40 – 3:00 PM EDT

Conference Wrap-Up: Meeting Observations From the Co-Chairs

  • Stephen “Fred” Divers, MD, Medical Oncologist, Genesis Cancer & Blood Institute & American Oncology Network
  • Debra Patt, MD, PhD, MBA, Vice President, Texas Oncology & The US Oncology Network
  • Jeffrey M. Patton, MD, Chief Executive Officer, OneOncology, Chairman of the Board, Tennessee Oncology
  • Alti Rahman, MHA, MBA, CSSBB, Practice Administrator, Oncology Consultants
  • Barry Russo, MBA, Chief Executive Officer, The Center for Cancer & Blood Disorders & OneOncology
  • Jeffrey Vacirca, MD, FACP, Chief Executive Officer, New York Cancer & Blood Specialists & OneOncology